Panacos Pharmaceuticals
Panacos Pharmaceuticals a drug company focused on HIV and other major human viral diseases.
Date | Investors | Amount | Round |
---|---|---|---|
$18.3m | Post IPO Equity | ||
$20.0m | Post IPO Equity | ||
N/A | N/A | IPO | |
$20.0m | Post IPO Debt | ||
Total Funding | - |
Related Content
Recent News about Panacos Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.